1. Home
  2. Insider Trading Stock Activity
  3. Turner Christopher Durant
Turner Christopher Durant

Turner Christopher Durant

Chief Medical Officer of NUVL

Stock Insider Trading Activity of Turner Christopher Durant

Turner Christopher Durant

Chief Medical Officer

Sell
NUVL Jan 6, 2026

Avg Cost/Share

$97.49

Shares

3,181

Total Value

$309,081.30

Owned After

56,990

SEC Form 4

Form 1 Form 2
Turner Christopher Durant

Chief Medical Officer

Sell
NUVL Jan 5, 2026

Avg Cost/Share

$97.35

Shares

4,236

Total Value

$412,239.09

Owned After

56,990

SEC Form 4

Turner Christopher Durant

Chief Medical Officer

Sell
NUVL Jan 6, 2025

Avg Cost/Share

$79.38

Shares

4,016

Total Value

$320,009.01

Owned After

56,990

SEC Form 4

Form 1 Form 2

Share on Social Networks: